Company Monitoring Page for Biogen

latest headlines for company on cafepharma

The clearest picture of Biogen's Alzheimer's drug is still fuzzy
Biopharma Dive
Thu, 12/5/19 - 11:34 pm
Tags:
Biogen, Alzheimer's disease, clinical trials, aducanumab
New Biogen data showed no major safety issues for its Alzheimer's drug
Reuters
Thu, 12/5/19 - 12:16 pm
Tags:
Biogen, safety, Alzheimer's disease, aducanumab, clinical trials
What to watch as Biogen presents its all-important Alzheimer's data
Biopharma Dive
Wed, 12/4/19 - 11:11 pm
Tags:
Biogen, clinical trials, Alzheimer's disease, aducanumab
'Positive surprise' for Biogen in lupus, but all eyes on CTAD data this week
Fierce Biotech
Tue, 12/3/19 - 10:20 pm
Tags:
Biogen, AstraZeneca, lupus, Amgen clinical trials, BIIB059
Biogen’s stock could fall 10% on new Alzheimer’s drug data this week, top analyst says
CNBC
Tue, 12/3/19 - 10:18 pm
Tags:
Biogen, Alzheimer's disease, aducanumab
Analyst: Biogen's aducanumab is not getting approved absent a deus ex machina
Fierce Biotech
Mon, 12/2/19 - 10:44 am
Tags:
Biogen, aducanumab, FDA, Alzheimer's disease
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
Tags:
ASH2019, Roche, Bristol-Myers Squibb, Acadia Pharmaceuticals, Biogen, Cassava Sciences, Alector, GW Pharma, Magenta Therapeutics, Fortress Biotech, Mustang Bio, Bluebird Bio
Why Biogen's Recent Rebound May Not Last -- at Least for Now
Motley Fool
Wed, 11/27/19 - 10:43 am
Tags:
Biogen, MS, multiple sclerois, Alzheimer's disease, Tecfidera, aducanumab
Roche, PTC will now get an FDA decision on their SMA drug in 6 months — facing off with Biogen, Novartis
Endpoints
Mon, 11/25/19 - 09:52 am
Tags:
Roche, PTC Therapeutics, SMA, risdiplam, Biogen, Spinraza
Patient charity to pay $4M to settle kickback allegations
Beckers Hospital Review
Fri, 11/22/19 - 10:12 am
Tags:
kickbacks, Medicare, Medicare fraud, MS, multiple sclerosis, Teva Pharmaceutical, Biogen, Novartis
Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug
Stat
Thu, 11/21/19 - 11:20 pm
Tags:
Biogen, aducanumab, FDA, Alzheimer's disease
Novartis, Merck KGaA and Biogen: Which new MS drug do doctors like best? You might be surprised
Fierce Pharma
Tue, 11/19/19 - 02:41 pm
Tags:
MS, multiple sclerosis, physicians, Novartis, Mayzent, Merck KGaA, Mavenclad, Biogen, Vumerity
Vumerity’s $88,000 List Price Not What ‘We Had Hoped,’ National MS Society Says
Multiple Sclerosis News Today
Thu, 11/14/19 - 07:35 pm
Tags:
Biogen, MS, multiple sclerosis, Vumerity, drug pricing, Tecfidera
Roche sets sights on Novartis, Biogen as SMA trial hits target
Yahoo/Reuters
Mon, 11/11/19 - 10:49 am
Tags:
Roche, SMA, risdiplam, Biogen, Novartis, clinical trials
DEAL WATCH: Biosimilars, Biosimilars and More Biosimilars
Big Molecule Watch
Sun, 11/10/19 - 07:55 pm
Tags:
biosimilars, Henlius, Ascentage, rituximab, Bioeq, Alvotech, Coherus, Biogen, Samsung Bioepis
Here's Why Biogen Stock Shot Up 28% in October
Motley Fool
Sun, 11/10/19 - 07:51 pm
Tags:
Biogen, Alzheimer's disease, aducanumab
Biogen hit back at whistleblowing sales manager, jury finds, levying $6M in damages
Fierce Pharma
Fri, 11/8/19 - 10:54 am
Tags:
Biogen, whistleblower lawsuit, retaliation claims, False Claims Act
Biogen signs marketing deal for two ophthalmology biosimilars
Pharmaforum
Thu, 11/7/19 - 10:16 am
Tags:
Biogen, ophthalmology, biosimilars, Europe, Japan, Samsung Bioepis, SB11, SB15, Lucentis, Eylea
Biogen ups investment in biosimilars
Marketwatch
Wed, 11/6/19 - 10:20 am
Tags:
Biogen, biosimilars, Samsung Bioepis
Biogen, Alkermes win FDA approval of Tecfidera successor — but can they actually sell it?
Endpoints
Wed, 10/30/19 - 10:13 am
Tags:
Biogen, Alkermes, FDA, multiple sclerosis, MS, Vumerity

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.